Search

everythinglearnresearchcommunity

for

Search:↓

Mice genetically modified to produce more CD109 in their skin had less inflammation and better healing with less scarring.

HDAC4 and HDAC7 are crucial for Th17 cell development and could be targeted to treat inflammatory diseases.

Using an anti-ICAM-1 antibody with rapamycin improves hair transplant survival in monkeys.

M50054 may help treat hepatitis and hair loss from chemotherapy.

CD3+ T-cell presence is a reliable marker to tell apart alopecia areata from pattern hair loss.

Enhancing regulatory T cells may help treat autoimmune diseases like alopecia areata.

GLI1 RNA CISH effectively identifies basal cell carcinoma but is less specific for benign follicular tumors.

Researchers found a new gene, hacl-1, that is active in mouse hair follicles during hair growth and may be important for hair biology.

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.

LRIG1 is linked to better survival in Merkel cell carcinoma.

Small molecules KY19382 and KY19334 may help treat skin cancer by reducing CDK1 levels and blocking harmful cell signals.

Intestinal intraepithelial lymphocytes are crucial for gut immunity and maintaining the mucosal barrier.

Checkpoint inhibitor therapy can cause skin issues, from mild rashes to severe reactions.

Melanocyte-associated antigens may play a key role in alopecia areata and could be targets for new treatments.

CD99 is highly present in certain skin cells and could help treat skin conditions.

CXCL12+ fibroblasts help recruit neutrophils to fight skin infections.

Tofacitinib helps improve skin conditions in people with Down syndrome, especially alopecia areata.

PH-762 shows promise in treating skin cancer by effectively targeting and silencing PD-1 in tumors with minimal side effects.

CD34 is absent in most basal cell carcinoma cells but present in surrounding skin.

CD27 and IL-35 can help diagnose alopecia areata linked to bacterial infections.

Patients with Alopecia areata have fewer specific immune cells that normally regulate the immune system, which may contribute to the condition.

Scientists found a new type of skin cell that could help with skin repair and these cells work better with a certain protein.

CD34 is crucial for skin tumor development in mice.

NCSTN gene mutation causes abnormal skin cell differentiation and more inflammation, contributing to Hidradenitis Suppurativa.

Alopecia areata involves specific immune cells, offering potential treatment targets.

IL-27 may help prevent hair loss by creating immune-suppressing cells.

The role of γδT-cells in causing alopecia areata remains unclear.

Cytotoxic T cells cause hair loss in chronic alopecia areata.

Myeloid-derived suppressor cells help control autoimmune cells and promote hair regrowth in alopecia areata.